These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24022467)

  • 1. COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.
    Makar KW; Poole EM; Resler AJ; Seufert B; Curtin K; Kleinstein SE; Duggan D; Kulmacz RJ; Hsu L; Whitton J; Carlson CS; Rimorin CF; Caan BJ; Baron JA; Potter JD; Slattery ML; Ulrich CM
    Cancer Causes Control; 2013 Dec; 24(12):2059-75. PubMed ID: 24022467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of PTGS1 and PTGS2 polymorphisms and NSAID intake on the risk of developing cancer.
    Nagao M; Sato Y; Yamauchi A
    PLoS One; 2013; 8(8):e71126. PubMed ID: 23967159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor genes and their association with colon and rectal cancer development and prognosis.
    Slattery ML; Herrick JS; Bondurant KL; Wolff RK
    Int J Cancer; 2012 Jun; 130(12):2974-80. PubMed ID: 21792899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin genes and associations with colon and rectal cancer risk and overall survival.
    Bondurant KL; Lundgreen A; Herrick JS; Kadlubar S; Wolff RK; Slattery ML
    Int J Cancer; 2013 Feb; 132(4):905-15. PubMed ID: 22674296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer.
    Slattery ML; Lundgreen A; Welbourn B; Corcoran C; Wolff RK
    PLoS One; 2012; 7(5):e37312. PubMed ID: 22615972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugs.
    St Germaine CG; Bogaty P; Boyer L; Hanley J; Engert JC; Brophy JM
    Am J Cardiol; 2010 Jun; 105(12):1740-5. PubMed ID: 20538124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
    Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTGS2 (COX2) -765G>C gene polymorphism and risk of sporadic colorectal cancer in Iranian population.
    Daraei A; Salehi R; Mohamadhashem F
    Mol Biol Rep; 2012 May; 39(5):5219-24. PubMed ID: 22173719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival.
    Slattery ML; Curtin K; Poole EM; Duggan DJ; Samowitz WS; Peters U; Caan BJ; Potter JD; Ulrich CM
    Int J Cancer; 2011 Jun; 128(11):2726-34. PubMed ID: 20949557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States).
    Slattery ML; Curtin K; Wolff R; Ma KN; Sweeney C; Murtaugh M; Potter JD; Levin TR; Samowitz W
    Cancer Causes Control; 2006 Apr; 17(3):239-49. PubMed ID: 16489531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs.
    Lee YS; Kim H; Wu TX; Wang XM; Dionne RA
    Clin Pharmacol Ther; 2006 May; 79(5):407-18. PubMed ID: 16678543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in the transforming growth factor-β-signaling pathway, lifestyle factors, and risk of colon or rectal cancer.
    Slattery ML; Lundgreen A; Wolff RK; Herrick JS; Caan BJ
    Dis Colon Rectum; 2012 May; 55(5):532-40. PubMed ID: 22513431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.
    Hubner RA; Muir KR; Liu JF; Logan RFA; Grainge MJ; Houlston RS;
    Int J Cancer; 2007 Nov; 121(9):2001-2004. PubMed ID: 17640058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study.
    Brasky TM; Bonner MR; Moysich KB; Ochs-Balcom HM; Marian C; Ambrosone CB; Nie J; Tao MH; Edge SB; Trevisan M; Shields PG; Freudenheim JL
    Breast Cancer Res Treat; 2011 Feb; 126(1):157-65. PubMed ID: 20676755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAP kinase genes and colon and rectal cancer.
    Slattery ML; Lundgreen A; Wolff RK
    Carcinogenesis; 2012 Dec; 33(12):2398-408. PubMed ID: 23027623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TERT's role in colorectal carcinogenesis.
    Pellatt AJ; Wolff RK; Herrick J; Lundgreen A; Slattery ML
    Mol Carcinog; 2013 Jul; 52(7):507-13. PubMed ID: 22351525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk.
    Thompson CL; Plummer SJ; Merkulova A; Cheng I; Tucker TC; Casey G; Li L
    World J Gastroenterol; 2009 May; 15(18):2240-4. PubMed ID: 19437564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between single nucleotide polymorphisms of COX-2 and MMP-2 genes and colorectal cancer susceptibility in the Saudi population.
    Shalaby MA; Nounou HA; Ms A; O A; Azzam N; Saeed HM
    Asian Pac J Cancer Prev; 2014; 15(12):4989-94. PubMed ID: 24998576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.
    Slattery ML; Herrick JS; Lundgreen A; Fitzpatrick FA; Curtin K; Wolff RK
    Carcinogenesis; 2010 Sep; 31(9):1604-11. PubMed ID: 20622004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of genetic polymorphisms in NFKB-mediated inflammatory pathways in response to primary chemoradiation therapy for rectal cancer.
    Dzhugashvili M; Luengo-Gil G; García T; González-Conejero R; Conesa-Zamora P; Escolar PP; Calvo F; Vicente V; Ayala de la Peña F
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):595-602. PubMed ID: 25304949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.